Schedule 13G ownership disclosure

Axsome Therapeutics Inc

Security class unavailable · CUSIP: 05464T104

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,064,158
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001033427-21-000006
Form type
SC 13G
Filer
Axsome Therapeutics, Inc.
CIK
CIK 1579428
Filed
Feb 04, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub